J.P. Morgan downgrades ARIAD Pharmaceuticals (Nasdaq: ARIA) from Overweight to Neutral.

ARIAD Pharmaceuticals, Inc ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE